{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:14:46Z","timestamp":1795025686227,"version":"4.10.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was funded by the Natural Science Foundation of Fujian Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Gallbladder cancer (GBC) is the most common malignant tumor of the biliary tract and is often prone to early distant metastasis. However, the mechanisms underlying GBC\u2019s invasive metastasis remain unclear. This study identified that F-box only protein 33 (FBXO33) expression is significantly elevated in GBC and is negatively associated with patient prognosis. In vivo and in vitro experiments demonstrated that knockdown of FBXO33 inhibits epithelial-mesenchymal transition (EMT) progression in GBC, while overexpression of FBXO33 promotes EMT progression. Mechanistically, FBXO33 regulates EMT progression by modulating the polyubiquitination of p53 at K291 and K292. Moreover, the upregulation of FBXO33 in GBC is driven by transcriptional regulation mediated by Yin Yang-1 (YY1). The lactylation modification of YY1 at K183 was found to be essential for the transcriptional activation of FBXO33. These findings underscore the role of the lactylation-driven FBXO33-p53 axis in promoting the invasive metastasis of GBC.<\/jats:p>","DOI":"10.1038\/s41419-025-07372-y","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:35:29Z","timestamp":1740749729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhenheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieshan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3488-1297","authenticated-orcid":false,"given":"Qiming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"7372_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garcia P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8:69.","journal-title":"Nat Rev Dis Primers"},{"key":"7372_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104319","volume":"85","author":"J Wang","year":"2022","unstructured":"Wang J, Ren M, Yu J, Hu M, Wang X, Ma W, et al. Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer. EBioMedicine. 2022;85:104319.","journal-title":"EBioMedicine"},{"key":"7372_CR3","first-page":"1352","volume":"78","author":"Y Li","year":"2023","unstructured":"Li Y, Yang B, Miao H, Liu L, Wang Z, Jiang C, et al. Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma. Hepatology. 2023;78:1352\u201367.","journal-title":"Hepatology"},{"key":"7372_CR4","doi-asserted-by":"publisher","first-page":"106234","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer: A review. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg"},{"key":"7372_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh M. Transcriptional regulation of EMT transcription factors in cancer. Semin Cancer Biol. 2023;97:21\u20139.","journal-title":"Semin Cancer Biol"},{"key":"7372_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605.","journal-title":"Cell Death Differ"},{"key":"7372_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","volume":"29","author":"D Han","year":"2023","unstructured":"Han D, Wang L, Jiang S, Yang Q. The ubiquitin-proteasome system in breast cancer. Trends Mol Med. 2023;29:599\u2013621.","journal-title":"Trends Mol Med"},{"key":"7372_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23:842\u201362.","journal-title":"Nat Rev Cancer"},{"key":"7372_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma DA, Chen Z, Bullock AN, Yamada KM. Ubiquitin ligases: guardians of mammalian development. Nat Rev Mol Cell Biol. 2022;23:350\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7372_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-019-1222-0","volume":"10","author":"Y Song","year":"2019","unstructured":"Song Y, Lin M, Liu Y, Wang ZW, Zhu X. Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers. Stem Cell Res Ther. 2019;10:124.","journal-title":"Stem Cell Res Ther"},{"key":"7372_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccr.2014.07.022","volume":"26","author":"H Zheng","year":"2014","unstructured":"Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, et al. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell. 2014;26:358\u201373.","journal-title":"Cancer Cell"},{"key":"7372_CR12","doi-asserted-by":"publisher","first-page":"e3002739","DOI":"10.1371\/journal.pbio.3002739","volume":"22","author":"C Simon","year":"2024","unstructured":"Simon C, Brunke ID, Stielow B, Forn\u00e9 I, Steitz AM, Geller M, et al. SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma. PLoS Biol. 2024;22:e3002739.","journal-title":"PLoS Biol"},{"key":"7372_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01366-x","volume":"8","author":"SK Sahu","year":"2017","unstructured":"Sahu SK, Tiwari N, Pataskar A, Zhuang Y, Borisova M, Diken M, et al. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development. Nat Commun. 2017;8:1523.","journal-title":"Nat Commun"},{"key":"7372_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06635-4","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Wen T, Marzio A, Song D, Chen S, Yang C, et al. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression. Cell Death Dis. 2024;15:282.","journal-title":"Cell Death Dis"},{"key":"7372_CR15","doi-asserted-by":"crossref","unstructured":"Wei Q, Liu Z, Zhu J, Jiang W, Xie H, Feng G, et al. The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc. Front Biosci. 2024;29:296.","DOI":"10.31083\/j.fbl2908296"},{"key":"7372_CR16","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u2013d7.","journal-title":"Nucleic Acids Res"},{"key":"7372_CR17","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019;47:D941\u2013d7.","journal-title":"Nucleic Acids Res"},{"key":"7372_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen CE, Wolberger C. New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 2014;21:301\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"7372_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00299-9","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017;8:347.","journal-title":"Nat Commun"},{"key":"7372_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson C, Wang Q, Otkur W, Zhao H, Lu Y, Liu X, et al. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin Transl Med. 2023;13:e1204.","journal-title":"Clin Transl Med"},{"key":"7372_CR21","doi-asserted-by":"crossref","unstructured":"Hao Q, Chen Y, Zhou X. The Janus Face of p53-Targeting Ubiquitin Ligases. Cells. 2020;9:1656.","DOI":"10.3390\/cells9071656"},{"key":"7372_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13420-x","volume":"10","author":"S Xu","year":"2019","unstructured":"Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492.","journal-title":"Nat Commun"},{"key":"7372_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s43018-024-00796-z","volume":"5","author":"G Efe","year":"2024","unstructured":"Efe G, Rustgi AK, Prives C. p53 at the crossroads of tumor immunity. Nat Cancer. 2024;5:983\u201395.","journal-title":"Nat Cancer"},{"key":"7372_CR24","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/s41418-021-00739-6","volume":"28","author":"Y Li","year":"2021","unstructured":"Li Y, Cui K, Zhang Q, Li X, Lin X, Tang Y, et al. FBXL6 degrades phosphorylated p53 to promote tumor growth. Cell Death Differ. 2021;28:2112\u201325.","journal-title":"Cell Death Differ"},{"key":"7372_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"7372_CR26","doi-asserted-by":"crossref","unstructured":"Huang J, Wang X, Li N, Fan W, Li X, Zhou Q, et al. YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes. Adv Sci. 2024;11:e2308031.","DOI":"10.1002\/advs.202308031"},{"key":"7372_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02931-y","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Fan W, Li N, Ma Y, Yao M, Wang G, et al. YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol. 2023;24:87.","journal-title":"Genome Biol"},{"key":"7372_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41418-020-00648-0","volume":"28","author":"F Dang","year":"2021","unstructured":"Dang F, Nie L, Wei W. Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death Differ. 2021;28:427\u201338.","journal-title":"Cell Death Differ"},{"key":"7372_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30376-7","volume":"13","author":"F Trulsson","year":"2022","unstructured":"Trulsson F, Akimov V, Robu M, van Overbeek N, Berrocal DAP, Shah RG, et al. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates. Nat Commun. 2022;13:2736.","journal-title":"Nat Commun"},{"key":"7372_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-020-00421-2","volume":"6","author":"X Zhou","year":"2021","unstructured":"Zhou X, Sun SC. Targeting ubiquitin signaling for cancer immunotherapy. Signal Transduct Target Ther. 2021;6:16.","journal-title":"Signal Transduct Target Ther"},{"key":"7372_CR31","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.7150\/thno.42735","volume":"10","author":"DS Tekcham","year":"2020","unstructured":"Tekcham DS, Chen D, Liu Y, Ling T, Zhang Y, Chen H, et al. F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects. Theranostics. 2020;10:4150\u201367.","journal-title":"Theranostics"},{"key":"7372_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2015.10.003","volume":"36","author":"VM D\u00edaz","year":"2016","unstructured":"D\u00edaz VM, de Herreros AG. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check. Semin Cancer Biol. 2016;36:71\u20139.","journal-title":"Semin Cancer Biol"},{"key":"7372_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216848","volume":"591","author":"L Zheng","year":"2024","unstructured":"Zheng L, Shen J, Chen Y, Lin J, Li P, Zhao X, et al. FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2. Cancer Lett. 2024;591:216848.","journal-title":"Cancer Lett"},{"key":"7372_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04675-2","volume":"13","author":"L Wu","year":"2022","unstructured":"Wu L, Yu K, Chen K, Zhu X, Yang Z, Wang Q, et al. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death Dis. 2022;13:231.","journal-title":"Cell Death Dis"},{"key":"7372_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jnc.14669","volume":"149","author":"ZS Chen","year":"2019","unstructured":"Chen ZS, Wong AKY, Cheng TC, Koon AC, Chan HYE. FipoQ\/FBXO33, a Cullin-1-based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein. J Neurochem. 2019;149:781\u201398.","journal-title":"J Neurochem"},{"key":"7372_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189035","volume":"1879","author":"C Zhang","year":"2024","unstructured":"Zhang C, Pan G, Qin JJ. Role of F-box proteins in human upper gastrointestinal tumors. Biochim Biophys Acta Rev Cancer. 2024;1879:189035.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7372_CR37","doi-asserted-by":"crossref","unstructured":"Loix M, Zelcer N, Bogie JFJ, Hendriks JJA. The ubiquitous role of ubiquitination in lipid metabolism. Trends Cell Biol. 2024;34:416\u201329.","DOI":"10.1016\/j.tcb.2023.09.001"},{"key":"7372_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102279","volume":"96","author":"A Kaushik","year":"2024","unstructured":"Kaushik A, Parashar S, Ambasta RK, Kumar P. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer. Ageing Res Rev. 2024;96:102279.","journal-title":"Ageing Res Rev"},{"key":"7372_CR39","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/emboj.2008.52","volume":"27","author":"J Lagirand-Cantaloube","year":"2008","unstructured":"Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, et al. The initiation factor eIF3-f is a major target for atrogin1\/MAFbx function in skeletal muscle atrophy. EMBO J. 2008;27:1266\u201376.","journal-title":"EMBO J"},{"key":"7372_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111762","volume":"42","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Cai GP, Feng X, Li YJ, Guo WH, Guo Q, et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. EMBO J. 2023;42:e111762.","journal-title":"EMBO J"},{"key":"7372_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1008368500557","volume":"10","author":"WM Gallagher","year":"1999","unstructured":"Gallagher WM, Brown R. p53-oriented cancer therapies: current progress. Ann Oncol. 1999;10:139\u201350.","journal-title":"Ann Oncol"},{"key":"7372_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semcancer.2010.02.006","volume":"20","author":"G Selivanova","year":"2010","unstructured":"Selivanova G. Therapeutic targeting of p53 by small molecules. Semin Cancer Biol. 2010;20:46\u201356.","journal-title":"Semin Cancer Biol"},{"key":"7372_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","volume":"20","author":"AJ Levine","year":"2020","unstructured":"Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20:471\u201380.","journal-title":"Nat Rev Cancer"},{"key":"7372_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc2693","volume":"9","author":"R Brosh","year":"2009","unstructured":"Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer. 2009;9:701\u201313.","journal-title":"Nat Rev Cancer"},{"key":"7372_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","volume":"74","author":"C Nepal","year":"2021","unstructured":"Nepal C, Zhu B, O\u2019Rourke CJ, Bhatt DK, Lee D, Song L, et al. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol. 2021;74:1132\u201344.","journal-title":"J Hepatol"},{"key":"7372_CR46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.trecan.2018.07.001","volume":"4","author":"T Soussi","year":"2018","unstructured":"Soussi T, Kroemer G. MDM2-TP53 Crossregulation: An Underestimated Target to Promote Loss of TP53 Function and Cell Survival. Trends Cancer. 2018;4:602\u20135.","journal-title":"Trends Cancer"},{"key":"7372_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1635-9","volume":"10","author":"Y Ning","year":"2019","unstructured":"Ning Y, Hui N, Qing B, Zhuo Y, Sun W, Du Y, et al. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation. Cell Death Dis. 2019;10:414.","journal-title":"Cell Death Dis"},{"key":"7372_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1208","volume":"13","author":"J Yao","year":"2023","unstructured":"Yao J, Wang XP, Yang J, Yang Z, Zhang ZY. SCF-FBXL8 contributes to liver metastasis and stem-cell-like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53. Clin Transl Med. 2023;13:e1208.","journal-title":"Clin Transl Med"},{"key":"7372_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37617-3","volume":"14","author":"J Yi","year":"2023","unstructured":"Yi J, Tavana O, Li H, Wang D, Baer RJ, Gu W. Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy. Nat Commun. 2023;14:1941.","journal-title":"Nat Commun"},{"key":"7372_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Li Q, Zhao G, Zhang J, Yuan H, Feng T, et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 2021;12:945.","journal-title":"Cell Death Dis"},{"key":"7372_CR51","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41418-023-01184-3","volume":"30","author":"Q Peng","year":"2023","unstructured":"Peng Q, Shi X, Li D, Guo J, Zhang X, Zhang X, et al. SCML2 contributes to tumor cell resistance to DNA damage through regulating p53 and CHK1 stability. Cell Death Differ. 2023;30:1849\u201367.","journal-title":"Cell Death Differ"},{"key":"7372_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1215995","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Liu W, Zhang L, Zhang J. Targeting mutant p53 stabilization for cancer therapy. Front Pharmacol. 2023;14:1215995.","journal-title":"Front Pharmacol"},{"key":"7372_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2016.39","volume":"2","author":"X Yue","year":"2016","unstructured":"Yue X, Zhao Y, Huang G, Li J, Zhu J, Feng Z, et al. A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis. Cell Discov. 2016;2:16039.","journal-title":"Cell Discov"},{"key":"7372_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.gendis.2020.11.007","volume":"9","author":"S Wang","year":"2022","unstructured":"Wang S, Hao Q, Li J, Chen Y, Lu H, Wu X, et al. Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development. Genes Dis. 2022;9:705\u201316.","journal-title":"Genes Dis"},{"key":"7372_CR55","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang C, Xu D, Zhang T, Chang CY, Wang J, et al. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Invest. 2023;133:e164354.","DOI":"10.1172\/JCI164354"},{"key":"7372_CR56","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/cdd.2011.71","volume":"18","author":"D Li","year":"2011","unstructured":"Li D, Marchenko ND, Moll UM. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ. 2011;18:1904\u201313.","journal-title":"Cell Death Differ"},{"key":"7372_CR57","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s41418-021-00762-7","volume":"28","author":"X Su","year":"2021","unstructured":"Su X, Feng C, Wang S, Shi L, Gu Q, Zhang H, et al. The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53. Cell Death Differ. 2021;28:2450\u201364.","journal-title":"Cell Death Differ"},{"key":"7372_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","volume":"43","author":"E Hays","year":"2019","unstructured":"Hays E, Bonavida B. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression. Drug Resist Updat. 2019;43:10\u201328.","journal-title":"Drug Resist Updat"},{"key":"7372_CR59","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","volume":"171","author":"AS Weintraub","year":"2017","unstructured":"Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, et al. YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017;171:1573\u201388.e28.","journal-title":"Cell"},{"key":"7372_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294\u2013311.e21.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07372-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:12:00Z","timestamp":1740751920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07372-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7372"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07372-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Research involving human subjects is reviewed and approved by the Ethics Committee of Fujian Medical University Union Hospital. Patients\/participants provide written informed consent to participate in this study. The animal study has been approved by the Ethics Committee of the Medical Faculty of the Fujian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"144"}}